Jpmorgan Chase & CO Silk Road Medical Inc Transaction History

Jpmorgan Chase & CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$16.95 - $27.04 $10,153 - $16,196	599 Added 1.75%	34,869 $942,000
Q1 2024 May 10, 2024	SELL	$11.38 - $19.03 $846,307 - $1.42 Million	-74,368 Reduced 68.45%	34,270 $627,000
Q4 2023 Feb 12, 2024	BUY	$6.29 - $15.72 $240,491 - $601,038	38,234 Added 54.31%	108,638 $1.33 Million
Q3 2023 Nov 14, 2023	SELL	$14.99 - $32.65 $566,741 - $1.23 Million	-37,808 Reduced 34.94%	70,404 $1.06 Million
Q2 2023 Aug 11, 2023	SELL	$29.76 - $46.14 $2.89 Million - $4.49 Million	-97,248 Reduced 47.33%	108,212 $3.52 Million
Q1 2023 May 18, 2023	BUY	$38.09 - $57.79 $1.81 Million - $2.74 Million	47,416 Added 30.0%	205,460 $8.04 Million
Q1 2023 May 11, 2023	BUY	$38.09 - $57.79 $2.1 Million - $3.19 Million	55,245 Added 53.74%	158,044 $6.18 Million
Q4 2022 Feb 13, 2023	SELL	$40.54 - $56.2 $498,642 - $691,260	-12,300 Reduced 10.69%	102,799 $5.43 Million
Q3 2022 Nov 14, 2022	SELL	$36.98 - $49.2 $126,138 - $167,821	-3,411 Reduced 2.88%	115,099 $5.18 Million
Q2 2022 Aug 11, 2022	BUY	$28.03 - $45.8 $1.37 Million - $2.24 Million	48,951 Added 70.37%	118,510 $4.31 Million
Q1 2022 May 11, 2022	SELL	$29.24 - $44.06 $9,853 - $14,848	-337 Reduced 0.48%	69,559 $2.87 Million
Q4 2021 Feb 10, 2022	SELL	$39.32 - $61.61 $470,188 - $736,732	-11,958 Reduced 14.61%	69,896 $2.98 Million
Q3 2021 Nov 12, 2021	BUY	$44.0 - $65.8 $3.6 Million - $5.39 Million	81,854 New	81,854 $4.51 Million

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.